Bio‑Techne and Refeyn close critical gap in bispecific antibody and biosimilar characterization

Companii

From Bio-Techne Jun 4 2026 Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‑of‑its‑kind integrated workflow for the characterization of charge and size variants in bispecific antibodies and biosimilars. By combining R&D Systems MauriceFlex ™ imaged capillary isoelectric focusing (icIEF) fractionation system with Refeyn's TwoMP mass photometry platform, researchers can